September 14, 1999
Tavist D Tablets, Antihistamine/Nasal
Decongestant Recalled by Novartis Consumer Health, Inc.
Lincoln, NE (SafetyAlerts) - The Food and Drug
Administration (FDA) today reported that Novartis Consumer Health, Inc. is recalling
Tavist D Tablets because of dissolution failure - Clemastine Fumarate (12 month stability
Tavist D Tablets, Antihistamine/Nasal Decongestant,
(Clemastine Fumarate, USP 1.34 mg/Phenylpropanolamine HCL, USP 75mg), 8 and 48 tablet
Recall #D-408-9. Class III
Lot numbers: 200145 EXP 10/2000 and 200146 EXP 10/2000.
Novartis Consumer Health, Inc., Lincoln, Nebraska.
Manufacturer, by letter dated June 7, 1999. Firm-initiated recall ongoing.
243,108 8-tablet packages and 40,680 48-tablet packages were distributed.
Safety Alerts compiles comprehensive safety
recall information for the United States. SafeMail is a free email service to warn
consumers of faulty products and contaminated foods. For complete information regarding
current recalls, past recalls and timely product warning notification visit: www.safetyalerts.com.